eu

The original PRISAR consortium implemented an innovative approach using imaging technologies and hybrid fluorescence/radionuclide probes for surgical intervention in cancer treatment. That project resulted in the development of a hybrid probe for image-guided surgery as well as a variety of additional tools and instruments. Now, the EU-funded PRISAR2 project aims to continue this effort by developing new industrial monitoring technologies for the surveillance of cancer. This innovative imaging-based platform will increase the surveillance window to allow for optimal selection of treatment options over time, possibly avoiding surgery. The 'watch and wait' strategies will enable better study of the cancer's progression so that any risks to the patient can be minimised leading to a better clinical outcome.

Info at Cordis

Partner

PROGREDUM GMBH, Germany, Partner
UNIVERSITE DE STRASBOURG, France, Partner
TECOBIOSCIENCES GMBH, Germany, Partner
THE UNIVERSITY OF LIVERPOOL, United Kingdom, Partner
UNIVERSITAETSMEDIZIN GOETTINGEN - GEORG-AUGUST-UNIVERSITAET GOETTINGEN - STIFTUNG OEFFENTLICHEN RECHTS, Germany, Partner
TACIT BIO INNOVATION LIMITED, United Kingdom, Partner
TECHNICKA UNIVERZITA VO ZVOLENE, Slovakia, Partner
SURGIMAB SAS, France, Partner
UNIVERSITA DEGLI STUDI DI NAPOLI FEDERICO II, Italy, Partner
THE UNIVERSITY OF SHEFFIELD, United Kingdom, Partner
CHIPDX IVS, Denmark, Partner
HAMMERSMITH MEDICINES RESEARCH LTD, United Kingdom, Partner
DATAR CANCER GENETICS (EUROPE) GMBH, Germany, Partner
ASSOCIAZIONE TOURISM, Italy, Partner
DES SOLUTIO - SOLUCOES E CONSULTORIA CIENTIFICA LDA, Portugal, Partner
ACADEMISCH ZIEKENHUIS LEIDEN, Netherlands, Partner
NEMI TERRITORIO E TURISMO, Italy, Partner
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM, Netherlands, Partner
ASSOCIAZIONE HAND IN HAND, Italy, Partner
HEINRICH-HEINE-UNIVERSITAET DUESSELDORF, Germany, Partner
THE UNIVERSITY OF EDINBURGH, United Kingdom, Partner
SERANOVO BV, Netherlands, Partner
FUJIFILM SONOSITE BV, Netherlands, Partner
PRISAR2
-
Partner
872860
Horizon 2020 - MSCA-RISE-2019 - Research and Innovation Staff Exchange
Commissione Europea –Programma H2020
 € 2 484 000
€ 110 400